GENMAB A/S -SP ADR (GMAB:NASDAQ)
$26.33 -0.71 (-2.6257%)
Analysed GENMAB A/S -SP ADR (GMAB:NASDAQ) News Sources
DARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion push
07-05-2026
yahoo.com
Genmab A/S Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Is It Time To Reassess Genmab (CPSE:GMAB) After Mixed Multi‑Year Share Performance
08-05-2026
yahoo.com
Major Shareholder Announcement
08-05-2026
yahoo.com
Junk-Rated Firms Rush to Reprice Risky Debt as Demand Surges
12-05-2026
yahoo.com
Capital Increase in Genmab as a Result of Employee Warrant Exercise
12-05-2026
yahoo.com
Morgan Stanley Maintains an “Equal Weight” Rating on Genmab A/S (GMAB)
13-05-2026
yahoo.com
Genmab (CPSE:GMAB) Valuation Check After Recent Share Price Softness And 24.6% Undervaluation Estimate
17-05-2026
yahoo.com
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
21-05-2026
yahoo.com
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
29-05-2026
yahoo.com
What is the current price of GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The current price of GENMAB A/S -SP ADR (GMAB:NASDAQ) is $26.33.
GENMAB A/S -SP ADR (GMAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of GENMAB A/S -SP ADR (GMAB:NASDAQ) since the previous trading day is $-0.71.
GENMAB A/S -SP ADR (GMAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of GENMAB A/S -SP ADR (GMAB:NASDAQ) since the previous trading day is -2.6257%.
What is the most recent average sentiment score for GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The most recent average sentiment score for GENMAB A/S -SP ADR (GMAB:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The most recent sentiment for GENMAB A/S -SP ADR (GMAB:NASDAQ) is .
SEC-8K** Filing Available For GENMAB A/S -SP ADR (GMAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.